Caixin App
Newsletter
Go
Sections
Sections
Finance
Business
Tech
Economy
China
World
Editorial & Opinion
Weekend Long Read
Research & Analysis
Lifestyle
Books & Arts
Blog
Video
Caixin Weekly Sneak Peek
Topics
Asia New Vision Forum 2024
War in Ukraine
Evergrande Crisis
ESG & Carbon Goals
China-U.S. Rivalry
Coronavirus
Hobbled Huawei
Digital Currency
Fintech / Internet Finance
Selected
CX Daily
Weekly Must-Read
Energy Insider
Economic Indexes
Caixin Explains
Reg Watch
Subscriber Events
ThinkChina
The Wall Street Journal
News Graphics
Market Data
Company Index
Podcast
Highlights
Newsletter
Events
ESG
Promotion
中文
SUBSCRIBE
Clear
GO
Sort by:
Newest
Newest
Relevance
Oldest
Type:
All
All
News
CX Tech
Videos
Podcast
Gallery
In-Depth
Time:
Any Time
Any time
Past 24 Hours
Past Week
Past Month
Past Year
Custom Range
Range:
All
All
Headline
Byline
Full Text
Reset
Showing search results for
di ning
Chinese Vaccine Maker Seeks Approval for Broad Use of Covid-19 Inoculation
Exclusive: Fosun and Germany’s BioNTech to Make Vaccine in China
Cover Story: The Daunting Challenge of Immunizing the World
In Blow to Fosun Pharma, Its German Partner to Make Covid-19 Vaccine for China Market
In Depth: Who’s Getting Vaccinated? High-Risk Groups, Students Going Abroad Join China's Growing Trials
Biopharma Firm Zai Lab Raises $825 Million in Hong Kong IPO
Scandal-Hit Legend Biotech’s Shares Bounce as Customs Probe Continues
China Looks to Overhaul State Health Insurance System
Cover Story: China Moves to Alter Medical Coverage of 300 Million
Experimental Covid-19 Vaccines Given to Hundreds of Thousands of Chinese
Load more
Sign In
Sign In
Cancel
Remember me
Forgot Password
OR
Sign in with Google
Sign in with Facebook
Sign in with 财新通